These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 9988278)

  • 1. Direct activation of TERT transcription by c-MYC.
    Wu KJ; Grandori C; Amacker M; Simon-Vermot N; Polack A; Lingner J; Dalla-Favera R
    Nat Genet; 1999 Feb; 21(2):220-4. PubMed ID: 9988278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.
    Greenberg RA; O'Hagan RC; Deng H; Xiao Q; Hann SR; Adams RR; Lichtsteiner S; Chin L; Morin GB; DePinho RA
    Oncogene; 1999 Feb; 18(5):1219-26. PubMed ID: 10022128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
    Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
    Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of myc and telomerase interactions in vivo.
    Flores I; Evan G; Blasco MA
    Mol Cell Biol; 2006 Aug; 26(16):6130-8. PubMed ID: 16880523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase and c-myc expression in hepatocellular carcinomas.
    Liu YC; Chen CJ; Wu HS; Chan DC; Yu JC; Yang AH; Cheng YL; Lee SC; Harn HJ
    Eur J Surg Oncol; 2004 May; 30(4):384-90. PubMed ID: 15063891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
    J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis.
    Shkreli M; Dambrine G; Soubieux D; Kut E; Rasschaert D
    J Virol; 2007 May; 81(9):4848-57. PubMed ID: 17314164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
    Maida Y; Kyo S; Kanaya T; Wang Z; Yatabe N; Tanaka M; Nakamura M; Ohmichi M; Gotoh N; Murakami S; Inoue M
    Oncogene; 2002 Jun; 21(26):4071-9. PubMed ID: 12037663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
    Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
    Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H; Urquidi V; Wong J; Kleeman J; Goodison S
    Mol Cancer Res; 2003 Aug; 1(10):739-46. PubMed ID: 12939399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ets2 transcription factor, telomerase activity and breast cancer.
    Dwyer JM; Liu JP
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):83-7. PubMed ID: 19566835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
    Packham G; Cleveland JL
    Oncogene; 1997 Sep; 15(10):1219-32. PubMed ID: 9294616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells.
    Wang Y; Duan HG; Chen SM; Xiao BK; Cheng J; Tao ZZ
    J Laryngol Otol; 2007 May; 121(5):476-82. PubMed ID: 17156515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT; Yang HT; Wang TC; Cheng AJ
    Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential transcriptional regulation of human telomerase in a cellular model representing important genetic alterations in esophageal squamous carcinogenesis.
    Quante M; Heeg S; von Werder A; Goessel G; Fulda C; Doebele M; Nakagawa H; Beijersbergen R; Blum HE; Opitz OG
    Carcinogenesis; 2005 Nov; 26(11):1879-89. PubMed ID: 15958520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.
    Oh S; Song YH; Kim UJ; Yim J; Kim TK
    Biochem Biophys Res Commun; 1999 Sep; 263(2):361-5. PubMed ID: 10491298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.
    Günes C; Lichtsteiner S; Vasserot AP; Englert C
    Cancer Res; 2000 Apr; 60(8):2116-21. PubMed ID: 10786671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.